Trade Heat Biologics, Inc. - HTBX CFD

2.179
4.62%
0.292
Low: 2.062
High: 2.249

Mon - Thu: 08:10 - 00:00

Fri: 08:10 - 21:00

Heat Biologics live chart

Trading Conditions
Long position overnight fee
-0.0225%
Short position overnight fee
-0.0219%
Overnight fee time
21:00 (UTC)
Min traded quantity
1
Currency
USD
Margin
20%
Stock exchange
United States of America
Commission on trade
0%
Content 2
Content 2
Content 2

Key Stats

Prev. Close* 2.121
Open* 2.1
Day's Range* 2.062 - 2.062
1-Year Change* -66.43%
Volume N/A
Average Vol. (3m) 3.16786
52 wk Range N/A
Market Cap 56.9426
P/E Ratio N/A
Shares Outstanding 25.65M
Revenue 1.78658
EPS -1.41213
Dividend (Yield %) N/A
Beta 0.45208
Next Earnings Date Aug 9, 2022
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

Heat Biologics Company profile

Heat Biologics, Inc., a biopharmaceutical company, focuses on developing immunotherapies to activate patient''s immune system against cancer through T-cell activation. The company''s T-cell activation platform, includes two variations for intradermal administration, such as immune pan-antigen cytotoxic therapy, an allogenic cell-based, T-cell-stimulating platform that functions as an immune activator to stimulate and expand T-cells; and combination pan-antigen cytotoxic therap, a dual-acting immunotherapy, which delivers antigen driven T-cell activation and specific co-stimulation in a single product. It is developing HS-110, which is in phase II clinical trials to treat patients with advanced non-small cell lung cancer. Its preclinical stage products include HS-130 for the treatment of advanced solid tumors; PTX-35, a humanized affinity matured monoclonal antibody, which is a functional agonist of human TNFRSF25 signaling; and PTX-45, a human TL1A-Ig fusion protein that acts as an agonist of TNFRSF25 signaling. The company has a strategic collaboration with the University of Miami Miller School of Medicine. Heat Biologics, Inc. was founded in 2008 and is headquartered in Durham, North Carolina.
Industry: Proprietary & Advanced Pharmaceuticals

627 Davis Drive
Suite 400
MORRISVILLE
NORTH CAROLINA 27560
US

People Also Watch

Ripple to US Dollar

0.38 Price
-2.670% 1D Chg, %
Long position overnight fee -0.0500%
Short position overnight fee 0.0140%
Overnight fee time 21:00 (UTC)
Spread 0.00600

Market analysis

Heat Biologics, Inc. (HTBX) Stock Moves 5.34%: What You Should Know

Heat Biologics, Inc. (HTBX) stock is up 5.34% in the last day. For details on what happened in the market, see our analysis.

07:00, 27 May 2022

Learn more about

Still looking for a broker you can trust?


Join the 380.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account

2. Make your first deposit

3. You’re all set. Start trading